News | July 22, 2014

Seven presentations at the 2014 American Association of Physicists in Medicine (AAPM) meeting focus on early adopters' work with Varian's Edge radiosurgery


July 22, 2014 — Medical researchers have confirmed the Edge radiosurgery system from Varian Medical Systems can deliver dose to a targeted tumor with sub-millimeter isocenter accuracy.  The researchers, from the Champalimaud Centre for the Unknown in Lisbon, Portugal, and other teams from the Henry Ford Health System in Detroit, Michigan, made seven scientific presentations about the Edge system during the 2014 American Association of Physicists in Medicine (AAPM) meeting from July 20-24. 

The Champalimaud team worked with scientists from Varian to conduct "end-to-end" testing of the Edge system, to demonstrate its diverse subsystems can work together to yield sub-millimeter accuracy when delivering dose.

Investigators from the Henry Ford Health System did early work with the Edge radiosurgery system covering a wide spectrum of clinical issues, from the accuracy of patient setup for image-guided intracranial (brain) radiosurgery to methods for accurately commissioning a new Edge system. One of the Henry Ford teams presented preliminary data on the accuracy of dose calculations for treating small, elongated tumors with radiosurgery. 

The Edge radiosurgery suite combines Varian's world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments. It integrates Varian's most advanced medical linear accelerator — a machine that produces the high energy X-ray beams used to treat disease — with tools for real-time imaging, tumor tracking, motion management and patient positioning. The Edge enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine and brain.

For more information: www.varian.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now